The Europe Orthopedic Biomaterials Market would witness market growth of 9.7% CAGR during the forecast period (2019-2025). Europe is the one of the largest markets in orthopedic biomaterials for the growing R&D activity in the field supported by government assistance and funds. Because of the available innovative treatment facilities and the increasing research operations in orthopedic biomaterials for nanotechnology, the industry is anticipated to grow. In addition to raising awareness of the population in terms of maintaining good health, growing instances in orthopedic surgeries foster market growth in the region.
The steadily increasing geriatric population mainly drives market growth, as people above the age of 65 have a high risk of developing degenerative disc disease, low bone density, and osteoarthritis. Moreover, the growing number of sports illness and the growing phenomena of road accidents boost the number of trauma cases and thus boost the demand for orthopedic implants.
Based on Material Type, the market is segmented into Emergency Care, Short-Term Stabilization, Trauma Care, Acute care surgery and Other Conditions. Based on Application, the market is segmented into Orthopedic Implants, Joint Replacements, Bio-resorbable Tissue Fixation, Orthobiologics and Visco Supplementation. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical, Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech, Inc., Collagen Matrix, Inc., Evonik Industries AG and Koninklijke DSM N.V. (DSM Biomedical B.V.).
Market Segmentation:
By Material Type
By Application
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 